GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Xvivo Perfusion AB (OSTO:XVIVO) » Definitions » Shiller PE Ratio

Xvivo Perfusion AB (OSTO:XVIVO) Shiller PE Ratio : 802.13 (As of Apr. 30, 2024)


View and export this data going back to 2012. Start your Free Trial

What is Xvivo Perfusion AB Shiller PE Ratio?

As of today (2024-04-30), Xvivo Perfusion AB's current share price is kr377.00. Xvivo Perfusion AB's E10 for the quarter that ended in Mar. 2024 was kr0.47. Xvivo Perfusion AB's Shiller PE Ratio for today is 802.13.

The historical rank and industry rank for Xvivo Perfusion AB's Shiller PE Ratio or its related term are showing as below:

OSTO:XVIVO' s Shiller PE Ratio Range Over the Past 10 Years
Min: 595.74   Med: 1446.15   Max: 1814.29
Current: 800.69

During the past years, Xvivo Perfusion AB's highest Shiller PE Ratio was 1814.29. The lowest was 595.74. And the median was 1446.15.

OSTO:XVIVO's Shiller PE Ratio is ranked worse than
100% of 276 companies
in the Medical Devices & Instruments industry
Industry Median: 26.93 vs OSTO:XVIVO: 800.69

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Xvivo Perfusion AB's adjusted earnings per share data for the three months ended in Mar. 2024 was kr0.720. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is kr0.47 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Xvivo Perfusion AB Shiller PE Ratio Historical Data

The historical data trend for Xvivo Perfusion AB's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Xvivo Perfusion AB Shiller PE Ratio Chart

Xvivo Perfusion AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 1,270.07 812.25

Xvivo Perfusion AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,373.29 1,577.77 1,435.57 812.25 590.32

Competitive Comparison of Xvivo Perfusion AB's Shiller PE Ratio

For the Medical Devices subindustry, Xvivo Perfusion AB's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Xvivo Perfusion AB's Shiller PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Xvivo Perfusion AB's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Xvivo Perfusion AB's Shiller PE Ratio falls into.



Xvivo Perfusion AB Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Xvivo Perfusion AB's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=377.00/0.47
=802.13

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Xvivo Perfusion AB's E10 for the quarter that ended in Mar. 2024 is calculated as:

For example, Xvivo Perfusion AB's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.72/130.9575*130.9575
=0.720

Current CPI (Mar. 2024) = 130.9575.

Xvivo Perfusion AB Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201406 0.040 100.432 0.052
201409 0.070 100.161 0.092
201412 0.050 100.225 0.065
201503 -0.002 99.950 -0.003
201506 0.050 99.995 0.065
201509 0.060 100.228 0.078
201512 0.130 100.276 0.170
201603 0.050 100.751 0.065
201606 0.070 101.019 0.091
201609 -0.020 101.138 -0.026
201612 -0.020 102.022 -0.026
201703 -0.002 102.022 -0.003
201706 0.040 102.752 0.051
201709 -0.010 103.279 -0.013
201712 0.210 103.793 0.265
201803 0.150 103.962 0.189
201806 0.150 104.875 0.187
201809 0.004 105.679 0.005
201812 0.180 105.912 0.223
201903 -0.010 105.886 -0.012
201906 0.080 106.742 0.098
201909 0.180 107.214 0.220
201912 -0.080 107.766 -0.097
202003 0.250 106.563 0.307
202006 -0.600 107.498 -0.731
202009 -0.510 107.635 -0.621
202012 -0.700 108.296 -0.846
202103 0.200 108.360 0.242
202106 -0.310 108.928 -0.373
202109 -0.040 110.338 -0.047
202112 0.420 112.486 0.489
202203 0.160 114.825 0.182
202206 0.260 118.384 0.288
202209 0.180 122.296 0.193
202212 0.020 126.365 0.021
202303 0.480 127.042 0.495
202306 0.230 129.407 0.233
202309 0.080 130.224 0.080
202312 2.290 130.958 2.290
202403 0.720 130.958 0.720

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Xvivo Perfusion AB  (OSTO:XVIVO) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Xvivo Perfusion AB Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Xvivo Perfusion AB's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Xvivo Perfusion AB (OSTO:XVIVO) Business Description

Traded in Other Exchanges
Address
Massans gata 10, P.O. Box 53015, Gothenburg, SWE, SE-400 14
Xvivo Perfusion AB is a medical technology company dedicated to extending the life of all major organs so transplant teams around the world can save more lives. Its solutions allow clinicians and researchers to push the boundaries of transplantation medicine. It operates in three segments namely, Thoracic: Sales of lung and heart transplant products, Abdominal: Sales of liver and kidney transplant products. Services: Revenue from sales of services in organ recovery (carried out by subsidiary STAR Teams Inc.). The majority of revenue is derived from the Thoracic segment. Geographically, the majority is from the United States.

Xvivo Perfusion AB (OSTO:XVIVO) Headlines

No Headlines